Skip to content
lifestyle.ebusinessplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nanobiotix S.A.
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
March 30, 2026
NANOBIOTIX Statement Regarding Recent Media Speculation
March 25, 2026
Voting Rights and Shares Capital of the Company
March 13, 2026
NANOBIOTIX to Participate in Investor Conferences in March
March 10, 2026
Voting Rights and Shares Capital of the Company
March 9, 2026
←
Previous Page
1
2